Abstract
Progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the following reduction in striatal dopamine cause Parkinson’s disease (PD). Transplantation of dopamine-producing cells into the striatum is a proposed treatment modality. In this report, we describe a model experiment assessing the effectiveness of mouse embryonic stem (ES) cell-derived dopaminergic neurons using a mouse model of PD. ES cells were shown to be an attractive and promising source for the generation of dopaminergic neurons, and the mouse PD model was useful to assess the efficacy of transplantation therapy with dopamineproducing cells, including ES cell-derived dopaminergic neurons.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee S. H., Lumelsky N., Studer L., Auerbach J. M., and McKay R. D. (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18, 675–679.
Kawasaki H., Suemori H., Mizuseki K., et al. (2002) Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc. Natl. Acad. Sci. USA 99, 1580–1585.
Park S., Lee K. S., Lee Y. J., et al. (2004) Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci. Lett. 359, 99–103.
Barberi T., Klivenyi P., Calingasan N. Y., et al. (2003) Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21, 1200–1207.
Kim J. H., Auerbach J. M., Rodriguez-Gomez J. A., Velasco I., Gavin D., and Lumelsky N. (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 418, 50–56.
Niwa H., Miyazaki J., and Smith A. G. (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372–376.
Hooper M., Hardy K., Handyside A., Hunter S., and Monk M. (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326, 292–295.
Kawasaki H., Mizuseki K., Nishikawa S., Kaneko S., Kuwana Y., and Nakanishi S.(2000) Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28, 31–40.
Kawasaki H., Mizuseki K., and Sasai Y. (2002) Selective neural induction from ES cells by stromal cell-derived inducing activity and its potential therapeutic application in Parkinson’s disease, in Methods in Molecular Biology Vol. 185 Embryonic Stem Cells. Methods and Protocols (Turksen K., ed), Humana Press, Totowa, NJ, pp. 217–227.
Nishimura F., Yoshikawa M., Kanda S., et al. (2003) Potential use of embryonic stem cellsfor the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 21, 171–180.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Nishimura, F., Toriumi, H., Ishizaka, S., Sakaki, T., Yoshikawa, M. (2006). Use of Differentiating Embryonic Stem Cells in the Parkinsonian Mouse Model. In: Turksen, K. (eds) Embryonic Stem Cell Protocols. Methods in Molecular Biology, vol 329. Humana Press. https://doi.org/10.1385/1-59745-037-5:485
Download citation
DOI: https://doi.org/10.1385/1-59745-037-5:485
Publisher Name: Humana Press
Print ISBN: 978-1-58829-498-2
Online ISBN: 978-1-59745-037-9
eBook Packages: Springer Protocols